P450 and Human Cancer

Japanese Journal of Cancer Research

Volumn 82, Issue 12, 1991, Pages 1325-1335

  Kawajiri, Kaname ^a   Fujii‐Kuriyama, Yoshiaki ^b  

^a SAITAMA CANCER CENTER   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Cancer etiology; Cytochrome P450; Metabolic activation

Indexed keywords

CARCINOGEN; CYTOCHROME P450;

BIOTRANSFORMATION; CANCER; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; ETIOLOGY; LIVER; METABOLIC ACTIVATION; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW;

ANIMAL; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; ISOENZYMES; NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026326770     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1991.tb01800.x     Document Type: Article

References (105)

1. P450 genes: structure, evolution, and regulation
2. Chemical carcinogenesis
3. The molecular biology of cytochrome P450s
4. Evolution, structure, and gene regulation of cytochrome P‐450
5. Characterization of human microsomal cytochrome P‐450 enzymes
6. Roles of cytochrome P‐450 enzymes in chemical carcinogenesis and cancer chemotherapy
7. Detection of carcinogens as mutagens in the Salmonella microsome test: assay of 300 chemicals
8. Detection of carcinogens as mutagens in the Salmonella/microtome test: assay of 300 chemicals: discussion
9. Environmental mutagens and carcinogens
10. Evaluation of the new test system (umu‐test) for the detection of environmental mutagens and carcinogens
11. Activation of carcinogenic compounds by purified cytochrome P‐450 in reconstituted systems
12. Metabolic activation of chemical carcinogens by two molecular species of cytochrome P‐450
13. 3‐450 DNA coding sequences as enzymatically active cytochromes P‐450 in mammalian cells
14. The P450 gene superfamily: update on new sequences, gene mapping, and recommended nomenclature
15. Human cDNA‐expressed cytochrome P450IA2: mutagen activation and substrate specificity
16. 1
17. Mutagenic activation of 2‐amino‐3‐methylimidazo[4,5‐f]‐quinoline by complementary DNA‐expressed human liver P‐450
18. Metabolism of 2‐acetylaminofluorene and benzo[a]pyrene and activation of food‐derived heterocyclic amine mutagens by human cytochrome P‐450
19. Human liver microsomal cytochrome P‐450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA. 1535/pSK1002
20. P. Roles of individual human cytochrome P‐450 enzymes in the bioactivation of benzo[a]pyrene, 7,8‐dihydroxy‐7,8‐dihydrobenzo[a]‐pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons
21. Evidence for cytochrome P‐450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver
22. 1 and 2‐amino‐3‐methyIimidazo[4,5‐f]‐quinoline by human adult and fetal livers
23. Purification and characterization of the human liver cytochromes P‐450 involved in debrisoquine 4‐hydroxylation and phenacetin O‐deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism
24. Debrisoquine/sparteine‐type polymorphism of drug oxidation
25. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
26. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine
27. Identification of the primary gene defect at the cytochrome P450 CYP2D locus
28. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma
29. Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes
30. Aryl hydrocarbon hydroxylase induction levels in patients with malignant tumors associated with smoking
31. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer
32. Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors
33. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene
34. Individual differences in lung cancer susceptibility in relation to polymorphisms of P450IA1 gene and cigarette dose
35. Lung cancer and the debrisoquine metabolic phenotype. J
36. Evolution and differentiation of P450 genes
37. 1‐450: complementary DNA and amino acid sequence
38. 1‐450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism
39. Structure and drug inducibility of the human cytochrome P‐450c gene
40. Nucleotide sequence of a full‐length cDNA for 3‐methylcholanthrene‐induced rat liver cytochrome P‐450MC
41. Distinct organization of raethylcholanthene‐ and phenobarbital‐inducible cytochrome P‐450 genes in the rat
42. 3‐450 cDNA nucleotide and amino acid sequences
43. 3‐450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues
44. Titration of mRNAs for cyto chrome P‐450c and P‐450d under drug‐inductive conditions in rat livers by their specific probes of cloned DNAs
45. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke‐induced gene expression in normal lung tissue and for pulmonary carcinomas
46. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction
47. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer Patients
48. Monoclonal antibody‐directed radio‐immunoassay detects cytochrome P‐450 in human placenta and lymphocytes
49. Regulatory DNA elements localized remotely upstream from the drug‐metabolizing cytochrome P‐450c gene
50. Characterization of xenobiotic responsive elements upstream from the drug‐metabolizing cytochrome P‐450c gene: a similarity to glucocorticoid regulatory elements
51. A DNA‐binding factor specific for xenobiotic responsive elements of P‐450c gene exists as a cryptic form in cytoplasm: its possible translocation to nucleus
52. A novel cisacting DNA element required for a high level of inducible expression of the rat P‐450c gene
53. Identification of multiple regulatory elements on the human cyto‐chrome P450IA1 gene
54. Xenobiotic responsive element in the 5′‐upstream region of the human P‐450c gene
55. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes
56. Distribution and reproducibility of aryl hydrocarbon hydroxylase inducibility in a prospective population study of middle‐aged male smokers and nonsmokers
57. Correlation of DNA adduct levels in human lung with cigarette smoking
58. Msp‐I polymorphism detected with a cDNA probe for the P‐450 I family on chromosome 15
59. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette dose
60. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP
61. Genetic linkage of lung cancer‐associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene
62. Identification of a human liver cytochrome P‐450 homologous to the major isosafrole‐inducible cytochrome P‐450 in the rat
63. Human cytochrome P‐450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA
64. Coding nucleotide sequence of 3‐methylcholanthrene‐iriducible cytochrome P‐450d cDNA from rat liver
65. Polymorphic metabolism of the carcinogen 2‐acetylaminofluorene in human liver microsomes
66. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin‐containing and cytochrome P‐450 monooxygenases
67. Metabolic oxidation of the carcinogens 4‐aminobiphenyl and 4,4′‐methylene‐bis(2‐chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P‐450 monooxygenases
68. Human cytochrome P‐450PA (P‐4501A2), the phenacetin O‐deethylase, is primarily responsible for the hepatic 3‐demethylation of caffeine and N‐oxidation of carcinogenic arylamines
69. Transcriptional and post‐transcriptional regulation of the genes encoding cyto‐chromes P450c and P450d in vivo and in primary hepato‐cyte cultures
70. The human cytochrome CyplA2 gene contains regulatory elements responsive to 3‐methylcholanthrene
71. Purification of liver microsomal cytochrome P‐450 isozymes 3a and 5 from imidazole‐treated rabbits: evidence for the identity of isozyme 3a with the form obtained by ethanol treatment
72. Characterization of a major form of rat hepatic microsomal cytochrome P‐450 induced by isoniazid
73. Purification and characterization of ethanol‐inducible human hepatic cytochrome P‐450HLj
74. Purification and characterization of human liver cytochrome P‐450‐ALC
75. Regulation of cytochrome P‐450j a high‐affinity N‐nitrosodimethylamine demethylase, in rat hepatic microsomes
76. cDNA and derived amino acid sequence of ethanol‐inducible rabbit liver cytochrome P‐450 isozyme 3a(P‐450ALC)
77. Complementary DNA and protein sequences of ethanol‐inducible rat and human cytochrome P‐450s
78. The rat P450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′‐cytosine demethylation
79. Human ethanol‐inducible P450I1E1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA‐directed expression
80. Organization and differential expression of two highly similar genes in the rabbit alcohol‐inducible cytochrome P‐450 subfamily
81. The nature of microsomal N‐nitrosodimethylamine demethylase and its role in carcinogen activation
82. Occurrence and exposure to N‐nitrosocompounds and precursors
83. Characterization of ethanol‐inducible human liver N‐nitrosodimethylamine demethylase
84. Metabolism of N‐nitrosodialkylamines by human liver micro‐somes
85. Genetics, polymorphisms and cDNA‐directed expression of human P‐450s
86. Induction of rat hepatic N‐nitrosodimethylamine demethylase by acetone is due to protein stabilization
87. The induction of a specific form of cytochrome P‐450(P‐450j) by fasting
88. Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat
89. Effect of ethanol on nitrosamine metabolism and distribution. Implications for the role of nitrosamines in human cancer and for the influence of alcohol consumption on cancer incidence
90. Pst I and Rsa I RFLPs in complete linkage disequilibrium at the CYP2E gene
91. Genetic polymorphisms in the 5′‐flanking region change transcriptional regulation of the human cytochrome P‐450IIE1 gene. J
92. Transcriptional control of the rat hepatic CYP2E1 gene
93. Complete cDNA sequence of a cytochrome P‐450 inducible by glucocorticoids in human liver
94. Isolation and sequence determination of a cDNA clone related to human cytochrome P‐450 nifedipine oxidase
95. Cytochrome P‐450hPCN3, a novel cytochrome P‐450IIIA gene product that is differentially expressed in adult human liver
96. Characterization of a cDNA encoding a new member of the glucocorticoid‐responsive cytochrome P450 in human liver
97. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P‐450
98. Purification and properties of cytochrome P‐450 from homogenates of human fetal livers
99. Identification of the human liver cytochrome P‐450 responsible for coumarin 7‐hydroxylase activity
100. The CYP2A3 gene product catalyzes coumarin 7‐hydroxylation in human liver microsomes
101. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1
102. Purification and characterization of six cytochrome P‐450 isozymes for human liver microsomes
103. Polymorphic hydroxylation of debrisoquine in man